Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PGK1 | P00558 | 1/20 | 0.36 |
| ▸ | PGK2 | P07205 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6045236 | 0.86 | CYP2A6 (0.42) | CYP2A6CYP1A2PTPN1SMN1; SMN2KDM4E | |
| SCHEMBL915284 | 0.86 | CYP1A2 (0.50) | CYP2A6CYP1A2POLBPTPN1FNTA | |
| SCHEMBL31688361 | 0.86 | CYP1A2 (0.50) | CYP2A6CYP1A2POLBPTPN1FNTA | |
| SCHEMBL3842481 | 0.85 | CETP (0.42) | S1PR1S1PR3 | |
| SCHEMBL914541 | 0.83 | PPARD (0.44) | POLBPPARDKDM4EALDH1A1RAB9A | |
| SCHEMBL8959089 | 0.81 | IDO1 (0.43) | SMN1; SMN2ALDH1A1HPGDPGK1PGK2 | |
| SCHEMBL17488978 | 0.79 | PPARD (0.50) | POLBPPARDSMN1; SMN2PGK1PGK2 | |
| SCHEMBL9166658 | 0.76 | NPY5R (0.42) | CYP2A6CYP1A2POLBPPARDHDAC1 | |
| SCHEMBL25922141 | 0.76 | HMGCR (0.56) | CYP2A6CYP1A2POLBEPHX2 | |
| SCHEMBL6045256 | 0.75 | PPARD (0.50) | POLBPPARDTDP1PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778699-A4 | TARGETING CHELANTS AND CHELATES | DOW GLOBAL TECHNOLOGIES INC (US) | 2009-02-25 | — | — | EP | disclosed |
| EP-1778699-A2 | TARGETING CHELANTS AND CHELATES | Dow Gloval Technologies Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| US-20060210479-A1 | Targeting chelants and chelates | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-21 | — | — | US | disclosed |
| WO-2006020779-A2 | TARGETING CHELANTS AND CHELATES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210479-A1 | Targeting chelants and chelates | CLTC, CALCOCO2, TFRC | CYP2A6 4582/4885CYP1A2 4844/4885POLB 2811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.